We are live on
!
Find out more
1CM
1492 Capital Management Portfolio holdings
AUM
$263M
1-Year Est. Return
61.9%
This Fund
S&P 500
This Quarter
Est. Return
-9.19%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$140M
AUM Growth
-$17.6M
(-11%)
Cap. Flow
+$1.43M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
34.65%
Holding
150
New
22
Increased
43
Reduced
43
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$2.19M |
| 2 |
GNBC
Green Bancorp, Inc
GNBC
|
+$1.75M |
| 3 |
LTXB
LegacyTexas Financial Group Inc
LTXB
|
+$1.61M |
| 4 |
Diamondback Energy
FANG
|
+$1.56M |
| 5 |
Nektar Therapeutics
NKTR
|
+$1.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
QuidelOrtho
QDEL
|
+$3.65M |
| 2 |
BGG
Briggs & Stratton Corp.
BGG
|
+$3.48M |
| 3 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
+$2.64M |
| 4 |
Carpenter Technology
CRS
|
+$1.76M |
| 5 |
Cogent Communications
CCOI
|
+$1.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.08% |
| 2 | Healthcare | 16.31% |
| 3 | Financials | 13.34% |
| 4 | Consumer Discretionary | 11.01% |
| 5 | Industrials | 7.95% |
Similar funds
KA
LCGC
DEA
EAN
PIP
VIG
SC
L
1492 Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, 1492 Capital Management held 150 positions worth $140M, down 11% from $158M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
1492 Capital Management's Q3 2015 filing shows 22 new, 43 increased, 43 reduced and 29 closed positions. Its largest new stake was Boingo Wireless, Inc.: 129,192 shares worth $1.07M. The largest sale was QuidelOrtho, an estimated $3.65M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- 1492 Capital Management's largest Q3 2015 buy was Boingo Wireless, Inc.: 129,192 shares worth $1.07M.
- 1492 Capital Management added most to BioTelemetry, Inc. in Q3 2015, an estimated $2.19M increase.
- 1492 Capital Management's biggest Q3 2015 reduction was Supernus Pharmaceuticals, cutting an estimated $1.12M.
- 1492 Capital Management fully exited QuidelOrtho in Q3 2015, selling an estimated $3.65M.
- 1492 Capital Management's ten largest holdings make up 35% of its $140M portfolio in Q3 2015.
- 1492 Capital Management opened 22 new positions and closed 29 in Q3 2015.
- 1492 Capital Management's portfolio value fell 11% quarter-over-quarter to $140M.
Based on 1492 Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.